The founder, Deboleena (Deb) Dutta graduated from Wharton and participated in the PCI I-Corps program with Viora Health.
A featured story on Katherine Sizov, founder of Strella Biotechnology, and how the company's sensors are reducing food waste and fighting climate change.
During this PCI webinar, Anish Kumar, the Managing Director of the Pennovation Works campus, discusses the past and future of Pennovation Works.
PCI hosted a webinar with Kirsten Leute and Margalit Haber of Osage University Partners on venture capital and investing for university entrepreneurs in the life science field
Penn Today marks the anniversary of Pennovation Works with a look at the evolution of the site, its research and commercialization achievements, and a glimpse into the future.
At Penn, a leader in GBM cellular therapies since the early days of this technology, a new CAR cell therapy could find its way into clinical trials by next year in collaboration with Tmunity.
NIH, FDA and 15 private organizations join forces to increase effective gene therapies for rare diseases
NIH, FDA, 10 pharmaceutical companies and five non-profit organizations have partnered to accelerate development of gene therapies for rare diseases.
The session, titled Feminine Energy: Female Founders Solving Sustainability Challenges, was a panel format featuring a Penn spinout, Pennovation tenants, and a Penn partner.
The company has now raised more than $35 million since its inception.
The Philadelphia Business Journal recently ranked the 20 highest-valued startups in Greater Philadelphia.